An interventional study of Intermittent Theta Burst Stimulation and Sham Intermittent Theta Burst Stimulation in Stroke, Hemiplegia and Hemiparesis After Stroke, sponsored by Danderyd Hospital. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-21.
Sponsored by Danderyd Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Stroke by Danderyd Hospital — 2 open to participants now, 2 under way, none of them phase 3. Stroke · Danderyd Hospital.
Among the 12 studies in Stroke by Danderyd Hospital, this one is the 2nd largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 10 with no phase, and was the 10th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →2 of the 12 studies in Stroke by Danderyd Hospital are open now, in 1 country. Recruiting first, the newest first:
Danderyd Hospital · Sites in Sweden
Ages 18+
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 48 is close to the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 22 across the 10 interventional studies, 53 across the 2 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Danderyd Hospital is the lead sponsor of 60 studies on the registry; 13 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Stroke by Danderyd Hospital, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effects and clinical feasibility of non-invasive brain stimulation protocols, specifically intermittent Theta Burst Stimulation, as part of rehabilitation interventions for motor recovery of upper extremity in the chronic phase after stroke.
It also seeks to explore the underlying mechanisms by investigating changes of functional and structural brain networks.
In this randomized controlled trial (RCT) group A will receive iTBS while group B will receive sham iTBS. Both groups will directly after the intervention receive 45 minutes of conventional physical therapy 3 times per week for 5 weeks, a total of 15 interventions by a blinded physiotherapist. For the iTBS intervention a Magstim Rapid² stimulator will be used also equipped with a Cadwell Sierra Summit EMG system [for motor evoked potential (MEP) measurements] and an ANT Visor2™ neuronavigation system [for navigated transcranial magnetic stimulation (TMS) interventions]. The iTBS parameters that will be used are: 600 pulses under 190 seconds at 80 % of Active Motor Threshold (AMT). The ipsilesional motor cortex will be targeted. The participants and clinical assessors will be blinded to the intervention.
All the patients will undergo advanced neuroimaging examinations before and after the intervention period. The exams will be then compared to identify neuroplastic changes in brain circuits.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The experimental group will receive intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the upper extremity led or instructed by a physiotherapist.
Device: Intermittent Theta Burst Stimulation
The placebo group will receive sham intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the lower extremity led or instructed by a physiotherapist.
Device: Sham Intermittent Theta Burst Stimulation
iTBS protocol: 600 pulses at 80% of AMT for 190 sec on the ipsilesional motor cortex, targeted with the support of a neuronavigational system, 15 sessions over a period of 5 weeks
Also known as: iTBS, TMS
It is identical to its active version, replicates operational sounds, and delivers a very shallow magnetic field to mimic the sensation of magnetic stimulation
Fugl-Meyer Assessment - Upper Extremity
used to quantify recovery of sensorimotor function in the upper extremity after a stroke. It is a 63 item test scored on a 3-level ordinal scale. The score ranges from 0 to 126 points. A higher score indicates recovery of sensorimotor function.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Modified Ashworth Scale (MAS)
Assesses spasticity on a 6 point scale/muscle (0p no impairment, 5p max impairment/muscle)
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Neuroflexor
Medical technology device. Assesses spasticity by identifying the neural, viscous and elastic components during passive movement using a biomechanical algorithm (presented in Newton)
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Box and Block Test (BBT)
measures unilateral gross manual dexterity. The score is based on the number of blocks transferred from one compartment to the other compartment in 60 seconds. Higher scores indicate better manual dexterity.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Action Research Arm Test (ARAT)
assesses upper extremity activity capacity in people with stroke. It is a 19-item test scored on a 4-level ordinal scale (0-3). The score ranges from 0 to 57. Higher scores indicate better performance of the upper extremity.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Dextrain Manipulandum™
allows measurement of flexion-extension finger movements. Force sensors are incorporated in the ergonomically designed tool allowing precision measurement of finger movements. The tool is coupled with specific exercises for evaluation of key components of manual dexterity.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Hand-held Dynamometer/Grip Strength
A quantitative and objective measure of isometric muscular strength of the hand and forearm. This instrument is scored using force production: kilograms or pounds. Maximum grip is the mean of three trials.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Purdue Pegboard Test (PPT)
is a test of fingertip dexterity and gross movement of the hand, fingers and arm in patients with impairments of the upper extremity resulting from neurological and musculoskeletal conditions. Number of correctly placed pinns within a time frame are counted and a higher scores indicate better dexterity.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Visuomotor force tracking
Subjects perform a visually guided, isometric precision grip ramp-and-hold force-tracking task by holding a manipulandum. The standardized visuomotor ramp-and-hold task is performed by following the target force with a cursor on a screen as precisely as possible.
Time frame: At baseline and after completion of the 5 week intervention and at the 12 weeks follow up, to assess changes
Montreal Cognitive Assessment (MoCA)
Assesses mental function (0p max impairment summed up to 30p no detected impairment)
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Canadian Occupational Performance Measure
Capture the participant´s perception of performance in everyday living and will be used to set goals for the intervention.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Stroke Impact Scale (SIS)
is a self-report questionnaire that evaluates disability and health-related quality of life after stroke. It has 8 domains: strength, hand function, mobility, physical and instrumental activities of daily living (ADL and IADL), memory and thinking, communication, emotion, and social participation. It uses a 5-point Likert scale to assess the difficulty of performing various tasks within each domain. Higher scores indicate better outcome.
Time frame: At baseline and after completion of the 5 week intervention and at the 12 weeks follow up, to assess changes
Motor Evoked Potentials (MEPs)
electrical signals recorded from neural tissue or muscle following activation of central motor pathways. MEPs assess the integrity of descending motor pathways.
Time frame: At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.
Resting state functional MRI (rs-fMRI)
a method aimed at examining intrinsic networks in the brain while no task is performed (rest); this is to estimate correlations between brain regions.
Time frame: At baseline and after completion of the 5 week intervention to assess changes.
Diffusion Tension Imaging (DTI)
a method aimed at mapping structural correlations between brain regions.
Time frame: At baseline and after completion of the 5 week intervention to assess changes.
National Institutes of Health Stroke Scale (NIHSS)
quantifies stroke severity based on weighted evaluation findings. The total NIHSS score ranges from 0 to 42, with higher scores indicating more severe strokes, categorized as follows: minor stroke (1-4), moderate stroke (5-15), moderate to severe stroke (16-20), and severe stroke (21-42).
Time frame: At baseline
Barthel Index (BI)
measures a person's ability to complete activities of daily living (ADL). Scores range from 0 to 100, categorized as follows: Total dependence (0-20), Severe dependence (21-60), Moderate dependence (61-90), Slight dependence (91-99), and Independence (100).
Time frame: At baseline.
Theoretical Framework of Acceptability questionnaire
to assess the acceptability of healthcare interventions, based on the developed Theoretical Framework of Acceptability (TFA). It uses a 5-point Likert scale to assess acceptability of the intervention. Higher scores indicate higher acceptability.
Time frame: After completion of the 5 week intervention to assess acceptability.
Plan to share: No
Start is estimated for Nov 2025; primary completion for Dec 2030, 61 months later.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 61 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Danderyd Hospital